Recent study in a group of German patients with SSc has implicated the SNP in the MCP-1 gene (-2518 A to G) as a factor of susceptibility to SSc. Reflecting the need for replication of genetic association studies, we investigated if this SNP is associated with SSc in another Caucasian population. MCP-1 -2518 A/G genotypes were determined using PCR-SSP in 46 SSc patients and in 449 healthy subjects, all unrelated and of Slovak (Slavonic) origin. The distribution of MCP-1 -2518 A/G genotypes complied with the Hardy-Weinberg equilibrium both in patient and healthy control groups. There was no difference in MCP-1 -2518*G allele frequency between SSc patients and healthy subjects (patients: 0.23; controls: 0.24; P > .05). Furthermore, MCP-1 -2518 GG homozygotes were similarly represented among SSc patients and healthy subjects (P > .05). The association of MCP-1 -2518 A/G SNP with SSc observed originally in German population was not replicated in the Slovak population.

Laboratory of Immunogenomics Department of Immunology Faculty of Medicine Palacky University 1 P Pavlova 6 775 20 Olomouc Czech Republic

Zobrazit více v PubMed

Assassi S, Tan FK. Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays. Current Opinion in Rheumatology. 2005;17(6):761–767. PubMed

Lee EB, Zhao J, Kim JY, Xiong M, Song YW. Evidence of potential interaction of chemokine genes in susceptibility to systemic sclerosis. Arthritis & Rheumatism. 2007;56(7):2443–2448. PubMed

Mattuzzi S, Barbi S, Carletto A, et al. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis. The Journal of Rheumatology. 2007;34(5):997–1004. PubMed

Steen V. Epidemiology and classification of scleroderma. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 4th edition. chapter 130, section 10. Amsterdam, The Netherlands: Mosby Elsevier; 2008. pp. 1361–1367.

Scala E, Pallotta S, Frezzolini A, et al. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clinical & Experimental Immunology. 2004;138(3):540–546. PubMed PMC

Yamamoto T, Eckes B, Hartmann K, Krieg T. Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis. Journal of Dermatological Science. 2001;26(2):133–139. PubMed

Distler O, Pap T, Kowal-Bielecka O, et al. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis & Rheumatism. 2001;44(11):2665–2678. PubMed

Galindo M, Santiago B, Rivero M, Rullas J, Alcami J, Pablos JL. Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression. Arthritis & Rheumatism. 2001;44(6):1382–1386. PubMed

Hasegawa M, Sato S, Takehara K. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP- 1), macrophage inflammatory protein-1α (MIP-1α) and MIP-1β) in patients with systemic sclerosis: MCP-1 and MIP-1α may be involved in the development of pulmonary fibrosis. Clinical & Experimental Immunology. 1999;117(1):159–165. PubMed PMC

Yamamoto T. Pathogenic role of CCL2/MCP-1 in scleroderma. Frontiers in Bioscience. 2008;13:2686–2695. PubMed

Sakai N, Wada T, Furuichi K, et al. MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes. Journal of Leukocyte Biology. 2006;79(3):555–563. PubMed

McDermott DH, Yang Q, Kathiresan S, et al. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation. 2005;112(8):1113–1120. PubMed

Karrer S, Bosserhoff AK, Weiderer P, et al. The −2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis. Journal of Investigative Dermatology. 2005;124(1):92–98. PubMed

Ioannidis JPA, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nature Genetics. 2001;29(3):306–309. PubMed

Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis & Rheumatism. 1980;23(5):581–590. PubMed

Cermakova Z, Petrkova J, Arakelyan A, et al. The MCP-1 −2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population. International Journal of Immunogenetics. 2005;32(5):315–318. PubMed

Lalouel J-M, Rohrwasser A. Power and replication in case-control studies. American Journal of Hypertension. 2002;15(2, part 1):201–205. PubMed

Krüger B, Schröppel B, Ashkan R, et al. A monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation. Journal of the American Society of Nephrology. 2002;13(10):2585–2589. PubMed

Kubistova Z, Mrazek F, Tudos Z, et al. Distribution of 22 cytokine gene polymorphisms in the healthy Czech population. International Journal of Immunogenetics. 2006;33(4):261–267. PubMed

Javor J, Bucova M, Ferencik S, Grosse-Wilde H, Buc M. Single nucleotide polymorphisms of cytokine genes in the healthy Slovak population. International Journal of Immunogenetics. 2007;34(4):273–280. PubMed